[Treatment of chronic obliterating arteritis: importance of a combination of vasodilator products].
D001167:Arteritis / Q000628:therapy*; D006801:Humans; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
ARTERITIS/therapy; VASOMOTOR DRUGS/therapeutic use
Contribution au traitement des artérites chroniques oblitérantes: intérêt d'une association de produits vaso-dilatateurs.